Atorvastatin accelerates Mycobacterium tuberculosis clearance in pulmonary TB: a randomised phase IIA trial

被引:9
作者
Adewole, O. O. [1 ,2 ,12 ]
Omotoso, B. A. [2 ,3 ]
Ogunsina, M. [4 ]
Aminu, A. [5 ]
Odeyemi, A. O. [6 ]
Awopeju, O. F. [2 ]
Ayoola, O. [7 ]
Adedeji, T. [8 ]
Sogaolu, O. M. [9 ]
Adewole, T. O. [10 ]
Jiya, E. [11 ]
Andero, V. [2 ]
Obaseki, D. [2 ]
Akintomide, A. O. [1 ,2 ]
Erhabor, G. E. [1 ,2 ]
机构
[1] Obafemi Awolowo Univ, Dept Med, Ife, Nigeria
[2] Obafemi Awolowo Univ, Teaching Hosp, Dept Med, Ife, Nigeria
[3] Obafemi Awolowo Univ, Clin Pharmacol & Therapeut Dept, Ife, Nigeria
[4] Kaduna State Univ, Dept Med, Kaduna, Nigeria
[5] Usman Fodiyo Univ, Dept Med, Sokoto, Nigeria
[6] Bowen Univ, Dept Med, Iwo, Nigeria
[7] Obafemi Awolowo Univ, Teaching Hosp, Dept Radiol, Ife, Nigeria
[8] Obafemi Awolowo Univ, Teaching Hosp, Dept Chem Pathol, Ife, Nigeria
[9] Univ Ibadan, Dept Med, Ibadan, Nigeria
[10] Obafemi Awolowo Univ, Teaching Hosp, Dept Family Med, Ife, Nigeria
[11] Natl TB Reference Lab, Zare, Kaduna, Nigeria
[12] Obafemi Awolowo Univ, Teaching Hosp, Resp Unit, Dept Med, Ife, Nigeria
关键词
EARLY BACTERICIDAL ACTIVITY; DRUGS;
D O I
10.5588/ijtld.22.0548
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
[No abstract available]
引用
收藏
页码:226 / 228
页数:3
相关论文
共 9 条
[1]   The early bactericidal activity of anti-tuberculosis drugs: a literature review [J].
Donald, P. R. ;
Diacon, A. H. .
TUBERCULOSIS, 2008, 88 :S75-S83
[2]  
JINDANI A, 1980, AM REV RESPIR DIS, V121, P939
[3]   Statin treatment is associated with a decreased risk of active tuberculosis: an analysis of a nationally representative cohort [J].
Lai, Chih-Cheng ;
Lee, Meng-tse Gabriel ;
Lee, Shih-Hao ;
Hsu, Wan-Ting ;
Chang, Shy-Shin ;
Chen, Shyr-Chyr ;
Lee, Chien-Chang .
THORAX, 2016, 71 (07) :646-651
[4]   Effect of HMG-CoA reductase inhibitors on activation of human γδT cells induced by Mycobacterium tuberculosis antigens [J].
Lue, He-Zuo ;
Li, Bai-Qing .
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2009, 31 (03) :485-491
[5]   Statin Therapy Reduces the Mycobacterium tuberculosis Burden in Human Macrophages and in Mice by Enhancing Autophagy and Phagosome Maturation [J].
Parihar, Suraj P. ;
Guler, Reto ;
Khutlang, Rethabile ;
Lang, Dirk M. ;
Hurdayal, Ramona ;
Mhlanga, Musa M. ;
Suzuki, Harukazu ;
Marais, A. David ;
Brombacher, Frank .
JOURNAL OF INFECTIOUS DISEASES, 2014, 209 (05) :754-763
[6]   A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP) [J].
Phillips, Patrick P. J. ;
Dooley, Kelly E. ;
Gillespie, Stephen H. ;
Heinrich, Norbert ;
Stout, Jason E. ;
Nahid, Payam ;
Diacon, Andreas H. ;
Aarnoutse, Rob E. ;
Kibiki, Gibson S. ;
Boeree, Martin J. ;
Hoelscher, Michael .
BMC MEDICINE, 2016, 14
[7]   Simvastatin increases the in vivo activity of the first-line tuberculosis regimen [J].
Skerry, Ciaran ;
Pinn, Michael L. ;
Bruiners, Natalie ;
Pine, Richard ;
Gennaro, Maria L. ;
Karakousis, Petros C. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (09) :2453-2457
[8]   Optimizing Outpatient Serial Sputum Colony Counting for Studies of Tuberculosis Treatment in Resource-Poor Settings [J].
Sloan, Derek J. ;
Corbett, Elizabeth L. ;
Butterworth, Anthony E. ;
Mwandumba, Henry C. ;
Khoo, Saye H. ;
Mdolo, Aaron ;
Shani, Doris ;
Kamdolozi, Mercy ;
Allen, Jenny ;
Mitchison, Denis A. ;
Coleman, David J. ;
Davies, Geraint R. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (07) :2315-2320
[9]   RANDOMIZATION AND STRATIFICATION OF PATIENTS TO CLINICAL TRIALS [J].
ZELEN, M .
JOURNAL OF CHRONIC DISEASES, 1974, 27 (7-8) :365-375